Orsiro®Mission

Is a next-generation drug-eluting stent (DES) designed for the treatment of de novo coronary lesions and in-stent restenotic lesions. It combines a thin-strut metallic platform with a controlled release of Sirolimus, promoting optimal healing and reducing the risk of restenosis.